Skip to main content
. Author manuscript; available in PMC: 2015 Oct 13.
Published in final edited form as: Cancer Cell. 2014 Sep 18;26(4):509–520. doi: 10.1016/j.ccr.2014.08.001

Table 1.

Clinical data of patients with the identified somatic CSNK1A1 mutations

#1 #2 #3
Age at diagnosis 85 82 65
Gender M F F
FAB RA RA RA
Karyotype 46, XY, del(5)(q13q31) [17]/46, XY[3] 46, XX, del(5)(q13q33)[14]/46, XX[6] 46, XX, del(5)(q13q33)[4]/46, XX[2]
IPSS-R 2, low risk 1, very low risk 1, very low risk
TP53 wild type wild type wild type
Hemoglobin [g/dL] 10.6 11.8 9.5
Absolute neutrophil count [109/l] 49.6 0.951 5.01
Platelets [cells/μl] 140,000 118,000 72,000

M: Male; F: Female; FAB: French-American-British classification; RA: Refractory Anemia. IPSS-R: revised International Prognostic Scoring System